Global Autoimmune Disease Treatment Device Market Growth (Status and Outlook) 2026-2032
The global Autoimmune Disease Treatment Device market size is predicted to grow from US$ 10031 million in 2025 to US$ 15354 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.
Autoimmune Disease Treatment Device refers to a category of medical devices designed to diagnose, manage, modulate, or therapeutically treat autoimmune disorders by regulating immune system activity, removing pathogenic substances from blood, delivering targeted stimulation, supporting biologic administration, or monitoring disease progression. These devices are used in the treatment of autoimmune conditions such as rheumatoid arthritis, lupus, multiple sclerosis, inflammatory bowel disease, psoriasis, myasthenia gravis, and type 1 diabetes. Autoimmune Disease Treatment Devices include plasmapheresis systems, immunoadsorption equipment, infusion pumps, neurostimulation devices, wearable monitoring systems, photopheresis systems, and targeted therapeutic delivery technologies that help improve disease management, reduce inflammatory activity, and enhance patient quality of life.
The Autoimmune Disease Treatment Device industry chain starts upstream with suppliers of medical-grade polymers, semiconductors, biosensors, filtration membranes, catheters, electronic components, biologic-compatible materials, and precision software systems, continues midstream through medical device manufacturers conducting product design, clinical testing, regulatory approval, intelligent system integration, assembly, sterilization, and distribution, and extends downstream to hospitals, specialty clinics, dialysis centers, research institutes, ambulatory care facilities, and homecare providers where devices are used for immune modulation, blood purification, biologic administration, disease monitoring, and long-term autoimmune disorder management, while service providers support maintenance, software upgrades, physician training, and post-treatment patient monitoring across global healthcare systems.
Current and planned projects in the Autoimmune Disease Treatment Device industry include expansion of blood purification device manufacturing facilities in North America and Europe, development of AI-enabled wearable immune monitoring platforms, establishment of advanced cleanroom assembly plants for biologic-compatible therapeutic devices, investment in smart neurostimulation technology production lines, construction of filtration membrane fabrication centers in Asia-Pacific, strategic partnerships between biotechnology companies and medical device manufacturers, localization of autoimmune treatment equipment manufacturing in emerging healthcare markets, modernization of robotic sterile assembly systems, development of remote patient management platforms, and large-scale R&D projects focused on personalized immune modulation technologies, minimally invasive treatment systems, digital therapeutics integration, and next-generation homecare autoimmune disease management solutions worldwide.
2025 Global Market Average Gross Profit Margin: 47%.
United States market for Autoimmune Disease Treatment Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Autoimmune Disease Treatment Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Autoimmune Disease Treatment Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Autoimmune Disease Treatment Device players cover Terumo Corporation, Fresenius Medical Care, Asahi Kasei Medical, Baxter, Therakos, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Autoimmune Disease Treatment Device Industry Forecast? looks at past sales and reviews total world Autoimmune Disease Treatment Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Autoimmune Disease Treatment Device sales for 2026 through 2032. With Autoimmune Disease Treatment Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autoimmune Disease Treatment Device industry.
This Insight Report provides a comprehensive analysis of the global Autoimmune Disease Treatment Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Autoimmune Disease Treatment Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Autoimmune Disease Treatment Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autoimmune Disease Treatment Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autoimmune Disease Treatment Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmune Disease Treatment Device market by product type, application, key players and key regions and countries.
Segmentation by Type:
Autoimmune Disease Treatment Device refers to a category of medical devices designed to diagnose, manage, modulate, or therapeutically treat autoimmune disorders by regulating immune system activity, removing pathogenic substances from blood, delivering targeted stimulation, supporting biologic administration, or monitoring disease progression. These devices are used in the treatment of autoimmune conditions such as rheumatoid arthritis, lupus, multiple sclerosis, inflammatory bowel disease, psoriasis, myasthenia gravis, and type 1 diabetes. Autoimmune Disease Treatment Devices include plasmapheresis systems, immunoadsorption equipment, infusion pumps, neurostimulation devices, wearable monitoring systems, photopheresis systems, and targeted therapeutic delivery technologies that help improve disease management, reduce inflammatory activity, and enhance patient quality of life.
The Autoimmune Disease Treatment Device industry chain starts upstream with suppliers of medical-grade polymers, semiconductors, biosensors, filtration membranes, catheters, electronic components, biologic-compatible materials, and precision software systems, continues midstream through medical device manufacturers conducting product design, clinical testing, regulatory approval, intelligent system integration, assembly, sterilization, and distribution, and extends downstream to hospitals, specialty clinics, dialysis centers, research institutes, ambulatory care facilities, and homecare providers where devices are used for immune modulation, blood purification, biologic administration, disease monitoring, and long-term autoimmune disorder management, while service providers support maintenance, software upgrades, physician training, and post-treatment patient monitoring across global healthcare systems.
Current and planned projects in the Autoimmune Disease Treatment Device industry include expansion of blood purification device manufacturing facilities in North America and Europe, development of AI-enabled wearable immune monitoring platforms, establishment of advanced cleanroom assembly plants for biologic-compatible therapeutic devices, investment in smart neurostimulation technology production lines, construction of filtration membrane fabrication centers in Asia-Pacific, strategic partnerships between biotechnology companies and medical device manufacturers, localization of autoimmune treatment equipment manufacturing in emerging healthcare markets, modernization of robotic sterile assembly systems, development of remote patient management platforms, and large-scale R&D projects focused on personalized immune modulation technologies, minimally invasive treatment systems, digital therapeutics integration, and next-generation homecare autoimmune disease management solutions worldwide.
2025 Global Market Average Gross Profit Margin: 47%.
United States market for Autoimmune Disease Treatment Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Autoimmune Disease Treatment Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Autoimmune Disease Treatment Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Autoimmune Disease Treatment Device players cover Terumo Corporation, Fresenius Medical Care, Asahi Kasei Medical, Baxter, Therakos, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Autoimmune Disease Treatment Device Industry Forecast? looks at past sales and reviews total world Autoimmune Disease Treatment Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Autoimmune Disease Treatment Device sales for 2026 through 2032. With Autoimmune Disease Treatment Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autoimmune Disease Treatment Device industry.
This Insight Report provides a comprehensive analysis of the global Autoimmune Disease Treatment Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Autoimmune Disease Treatment Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Autoimmune Disease Treatment Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autoimmune Disease Treatment Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autoimmune Disease Treatment Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmune Disease Treatment Device market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Therapeutic Apheresis Devices
- Immunoadsorption Devices
- Extracorporeal Photopheresis (ECP) Systems
- Blood Purification Devices
- Cell Therapy / Immune Modulation Devices
- Neuromodulation Devices
- Others
- Stationary Device
- Portable Device
- Wearable Device
- Blood Purification
- Immune Modulation
- Inflammation Suppression
- Neuromodulation
- Biologic Drug Administration
- Others
- Systemic Autoimmune Diseases
- Gastrointestinal Autoimmune Disease
- Neurological Autoimmune Disorders
- Autoimmune Kidney Disease
- Dermatological Autoimmune Conditions
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Terumo Corporation
- Fresenius Medical Care
- Asahi Kasei Medical
- Baxter
- Therakos
- PhotoMedex
- Nikkiso Co., Ltd
- SWS Hemodialysis Care Co., Ltd
- WEGOBP
- Haemonetics
- Miltenyi Biotec
- B. Braun
- Kaneka
- Medica S.r.l / Aferetica
- Cala Health
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Autoimmune Disease Treatment Device Market Size (2021-2032)
2.1.2 Autoimmune Disease Treatment Device Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Autoimmune Disease Treatment Device by Country/Region (2021, 2025 & 2032)
2.2 Autoimmune Disease Treatment Device Segment by Type
2.2.1 Therapeutic Apheresis Devices
2.2.2 Immunoadsorption Devices
2.2.3 Extracorporeal Photopheresis (ECP) Systems
2.2.4 Blood Purification Devices
2.2.5 Cell Therapy / Immune Modulation Devices
2.2.6 Neuromodulation Devices
2.2.7 Others
2.2.8 Autoimmune Disease Treatment Device Market Size by Type
2.2.8.1 Autoimmune Disease Treatment Device Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.8.2 Global Autoimmune Disease Treatment Device Market Size Market Share by Type (2021-2026)
2.3 Autoimmune Disease Treatment Device Segment by Device Mobility
2.3.1 Stationary Device
2.3.2 Portable Device
2.3.3 Wearable Device
2.3.4 Autoimmune Disease Treatment Device Market Size by Device Mobility
2.3.4.1 Autoimmune Disease Treatment Device Market Size CAGR by Device Mobility (2021 VS 2025 VS 2032)
2.3.4.2 Global Autoimmune Disease Treatment Device Market Size Market Share by Device Mobility (2021-2026)
2.4 Autoimmune Disease Treatment Device Segment by Therapeutic Mechanism
2.4.1 Blood Purification
2.4.2 Immune Modulation
2.4.3 Inflammation Suppression
2.4.4 Neuromodulation
2.4.5 Biologic Drug Administration
2.4.6 Others
2.4.7 Autoimmune Disease Treatment Device Market Size by Therapeutic Mechanism
2.4.7.1 Autoimmune Disease Treatment Device Market Size CAGR by Therapeutic Mechanism (2021 VS 2025 VS 2032)
2.4.7.2 Global Autoimmune Disease Treatment Device Market Size Market Share by Therapeutic Mechanism (2021-2026)
2.5 Autoimmune Disease Treatment Device Segment by Application
2.5.1 Systemic Autoimmune Diseases
2.5.2 Gastrointestinal Autoimmune Disease
2.5.3 Neurological Autoimmune Disorders
2.5.4 Autoimmune Kidney Disease
2.5.5 Dermatological Autoimmune Conditions
2.5.6 Autoimmune Disease Treatment Device Market Size by Application
2.5.6.1 Autoimmune Disease Treatment Device Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.6.2 Global Autoimmune Disease Treatment Device Market Size Market Share by Application (2021-2026)
3 AUTOIMMUNE DISEASE TREATMENT DEVICE MARKET SIZE BY PLAYER
3.1 Autoimmune Disease Treatment Device Market Size Market Share by Player
3.1.1 Global Autoimmune Disease Treatment Device Revenue by Player (2021-2026)
3.1.2 Global Autoimmune Disease Treatment Device Revenue Market Share by Player (2021-2026)
3.2 Global Autoimmune Disease Treatment Device Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AUTOIMMUNE DISEASE TREATMENT DEVICE BY REGION
4.1 Autoimmune Disease Treatment Device Market Size by Region (2021-2026)
4.2 Global Autoimmune Disease Treatment Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Autoimmune Disease Treatment Device Market Size Growth (2021-2026)
4.4 APAC Autoimmune Disease Treatment Device Market Size Growth (2021-2026)
4.5 Europe Autoimmune Disease Treatment Device Market Size Growth (2021-2026)
4.6 Middle East & Africa Autoimmune Disease Treatment Device Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Autoimmune Disease Treatment Device Market Size by Country (2021-2026)
5.2 Americas Autoimmune Disease Treatment Device Market Size by Type (2021-2026)
5.3 Americas Autoimmune Disease Treatment Device Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autoimmune Disease Treatment Device Market Size by Region (2021-2026)
6.2 APAC Autoimmune Disease Treatment Device Market Size by Type (2021-2026)
6.3 APAC Autoimmune Disease Treatment Device Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Autoimmune Disease Treatment Device Market Size by Country (2021-2026)
7.2 Europe Autoimmune Disease Treatment Device Market Size by Type (2021-2026)
7.3 Europe Autoimmune Disease Treatment Device Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Autoimmune Disease Treatment Device by Region (2021-2026)
8.2 Middle East & Africa Autoimmune Disease Treatment Device Market Size by Type (2021-2026)
8.3 Middle East & Africa Autoimmune Disease Treatment Device Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AUTOIMMUNE DISEASE TREATMENT DEVICE MARKET FORECAST
10.1 Global Autoimmune Disease Treatment Device Forecast by Region (2027-2032)
10.1.1 Global Autoimmune Disease Treatment Device Forecast by Region (2027-2032)
10.1.2 Americas Autoimmune Disease Treatment Device Forecast
10.1.3 APAC Autoimmune Disease Treatment Device Forecast
10.1.4 Europe Autoimmune Disease Treatment Device Forecast
10.1.5 Middle East & Africa Autoimmune Disease Treatment Device Forecast
10.2 Americas Autoimmune Disease Treatment Device Forecast by Country (2027-2032)
10.2.1 United States Market Autoimmune Disease Treatment Device Forecast
10.2.2 Canada Market Autoimmune Disease Treatment Device Forecast
10.2.3 Mexico Market Autoimmune Disease Treatment Device Forecast
10.2.4 Brazil Market Autoimmune Disease Treatment Device Forecast
10.3 APAC Autoimmune Disease Treatment Device Forecast by Region (2027-2032)
10.3.1 China Autoimmune Disease Treatment Device Market Forecast
10.3.2 Japan Market Autoimmune Disease Treatment Device Forecast
10.3.3 Korea Market Autoimmune Disease Treatment Device Forecast
10.3.4 Southeast Asia Market Autoimmune Disease Treatment Device Forecast
10.3.5 India Market Autoimmune Disease Treatment Device Forecast
10.3.6 Australia Market Autoimmune Disease Treatment Device Forecast
10.4 Europe Autoimmune Disease Treatment Device Forecast by Country (2027-2032)
10.4.1 Germany Market Autoimmune Disease Treatment Device Forecast
10.4.2 France Market Autoimmune Disease Treatment Device Forecast
10.4.3 UK Market Autoimmune Disease Treatment Device Forecast
10.4.4 Italy Market Autoimmune Disease Treatment Device Forecast
10.4.5 Russia Market Autoimmune Disease Treatment Device Forecast
10.5 Middle East & Africa Autoimmune Disease Treatment Device Forecast by Region (2027-2032)
10.5.1 Egypt Market Autoimmune Disease Treatment Device Forecast
10.5.2 South Africa Market Autoimmune Disease Treatment Device Forecast
10.5.3 Israel Market Autoimmune Disease Treatment Device Forecast
10.5.4 Turkey Market Autoimmune Disease Treatment Device Forecast
10.6 Global Autoimmune Disease Treatment Device Forecast by Type (2027-2032)
10.7 Global Autoimmune Disease Treatment Device Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Autoimmune Disease Treatment Device Forecast
11 KEY PLAYERS ANALYSIS
11.1 Terumo Corporation
11.1.1 Terumo Corporation Company Information
11.1.2 Terumo Corporation Autoimmune Disease Treatment Device Product Offered
11.1.3 Terumo Corporation Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Terumo Corporation Main Business Overview
11.1.5 Terumo Corporation Latest Developments
11.2 Fresenius Medical Care
11.2.1 Fresenius Medical Care Company Information
11.2.2 Fresenius Medical Care Autoimmune Disease Treatment Device Product Offered
11.2.3 Fresenius Medical Care Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Fresenius Medical Care Main Business Overview
11.2.5 Fresenius Medical Care Latest Developments
11.3 Asahi Kasei Medical
11.3.1 Asahi Kasei Medical Company Information
11.3.2 Asahi Kasei Medical Autoimmune Disease Treatment Device Product Offered
11.3.3 Asahi Kasei Medical Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Asahi Kasei Medical Main Business Overview
11.3.5 Asahi Kasei Medical Latest Developments
11.4 Baxter
11.4.1 Baxter Company Information
11.4.2 Baxter Autoimmune Disease Treatment Device Product Offered
11.4.3 Baxter Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Baxter Main Business Overview
11.4.5 Baxter Latest Developments
11.5 Therakos
11.5.1 Therakos Company Information
11.5.2 Therakos Autoimmune Disease Treatment Device Product Offered
11.5.3 Therakos Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Therakos Main Business Overview
11.5.5 Therakos Latest Developments
11.6 PhotoMedex
11.6.1 PhotoMedex Company Information
11.6.2 PhotoMedex Autoimmune Disease Treatment Device Product Offered
11.6.3 PhotoMedex Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 PhotoMedex Main Business Overview
11.6.5 PhotoMedex Latest Developments
11.7 Nikkiso Co., Ltd
11.7.1 Nikkiso Co., Ltd Company Information
11.7.2 Nikkiso Co., Ltd Autoimmune Disease Treatment Device Product Offered
11.7.3 Nikkiso Co., Ltd Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Nikkiso Co., Ltd Main Business Overview
11.7.5 Nikkiso Co., Ltd Latest Developments
11.8 SWS Hemodialysis Care Co., Ltd
11.8.1 SWS Hemodialysis Care Co., Ltd Company Information
11.8.2 SWS Hemodialysis Care Co., Ltd Autoimmune Disease Treatment Device Product Offered
11.8.3 SWS Hemodialysis Care Co., Ltd Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 SWS Hemodialysis Care Co., Ltd Main Business Overview
11.8.5 SWS Hemodialysis Care Co., Ltd Latest Developments
11.9 WEGOBP
11.9.1 WEGOBP Company Information
11.9.2 WEGOBP Autoimmune Disease Treatment Device Product Offered
11.9.3 WEGOBP Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 WEGOBP Main Business Overview
11.9.5 WEGOBP Latest Developments
11.10 Haemonetics
11.10.1 Haemonetics Company Information
11.10.2 Haemonetics Autoimmune Disease Treatment Device Product Offered
11.10.3 Haemonetics Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Haemonetics Main Business Overview
11.10.5 Haemonetics Latest Developments
11.11 Miltenyi Biotec
11.11.1 Miltenyi Biotec Company Information
11.11.2 Miltenyi Biotec Autoimmune Disease Treatment Device Product Offered
11.11.3 Miltenyi Biotec Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Miltenyi Biotec Main Business Overview
11.11.5 Miltenyi Biotec Latest Developments
11.12 B. Braun
11.12.1 B. Braun Company Information
11.12.2 B. Braun Autoimmune Disease Treatment Device Product Offered
11.12.3 B. Braun Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 B. Braun Main Business Overview
11.12.5 B. Braun Latest Developments
11.13 Kaneka
11.13.1 Kaneka Company Information
11.13.2 Kaneka Autoimmune Disease Treatment Device Product Offered
11.13.3 Kaneka Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Kaneka Main Business Overview
11.13.5 Kaneka Latest Developments
11.14 Medica S.r.l / Aferetica
11.14.1 Medica S.r.l / Aferetica Company Information
11.14.2 Medica S.r.l / Aferetica Autoimmune Disease Treatment Device Product Offered
11.14.3 Medica S.r.l / Aferetica Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Medica S.r.l / Aferetica Main Business Overview
11.14.5 Medica S.r.l / Aferetica Latest Developments
11.15 Cala Health
11.15.1 Cala Health Company Information
11.15.2 Cala Health Autoimmune Disease Treatment Device Product Offered
11.15.3 Cala Health Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Cala Health Main Business Overview
11.15.5 Cala Health Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Autoimmune Disease Treatment Device Market Size (2021-2032)
2.1.2 Autoimmune Disease Treatment Device Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Autoimmune Disease Treatment Device by Country/Region (2021, 2025 & 2032)
2.2 Autoimmune Disease Treatment Device Segment by Type
2.2.1 Therapeutic Apheresis Devices
2.2.2 Immunoadsorption Devices
2.2.3 Extracorporeal Photopheresis (ECP) Systems
2.2.4 Blood Purification Devices
2.2.5 Cell Therapy / Immune Modulation Devices
2.2.6 Neuromodulation Devices
2.2.7 Others
2.2.8 Autoimmune Disease Treatment Device Market Size by Type
2.2.8.1 Autoimmune Disease Treatment Device Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.8.2 Global Autoimmune Disease Treatment Device Market Size Market Share by Type (2021-2026)
2.3 Autoimmune Disease Treatment Device Segment by Device Mobility
2.3.1 Stationary Device
2.3.2 Portable Device
2.3.3 Wearable Device
2.3.4 Autoimmune Disease Treatment Device Market Size by Device Mobility
2.3.4.1 Autoimmune Disease Treatment Device Market Size CAGR by Device Mobility (2021 VS 2025 VS 2032)
2.3.4.2 Global Autoimmune Disease Treatment Device Market Size Market Share by Device Mobility (2021-2026)
2.4 Autoimmune Disease Treatment Device Segment by Therapeutic Mechanism
2.4.1 Blood Purification
2.4.2 Immune Modulation
2.4.3 Inflammation Suppression
2.4.4 Neuromodulation
2.4.5 Biologic Drug Administration
2.4.6 Others
2.4.7 Autoimmune Disease Treatment Device Market Size by Therapeutic Mechanism
2.4.7.1 Autoimmune Disease Treatment Device Market Size CAGR by Therapeutic Mechanism (2021 VS 2025 VS 2032)
2.4.7.2 Global Autoimmune Disease Treatment Device Market Size Market Share by Therapeutic Mechanism (2021-2026)
2.5 Autoimmune Disease Treatment Device Segment by Application
2.5.1 Systemic Autoimmune Diseases
2.5.2 Gastrointestinal Autoimmune Disease
2.5.3 Neurological Autoimmune Disorders
2.5.4 Autoimmune Kidney Disease
2.5.5 Dermatological Autoimmune Conditions
2.5.6 Autoimmune Disease Treatment Device Market Size by Application
2.5.6.1 Autoimmune Disease Treatment Device Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.6.2 Global Autoimmune Disease Treatment Device Market Size Market Share by Application (2021-2026)
3 AUTOIMMUNE DISEASE TREATMENT DEVICE MARKET SIZE BY PLAYER
3.1 Autoimmune Disease Treatment Device Market Size Market Share by Player
3.1.1 Global Autoimmune Disease Treatment Device Revenue by Player (2021-2026)
3.1.2 Global Autoimmune Disease Treatment Device Revenue Market Share by Player (2021-2026)
3.2 Global Autoimmune Disease Treatment Device Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AUTOIMMUNE DISEASE TREATMENT DEVICE BY REGION
4.1 Autoimmune Disease Treatment Device Market Size by Region (2021-2026)
4.2 Global Autoimmune Disease Treatment Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Autoimmune Disease Treatment Device Market Size Growth (2021-2026)
4.4 APAC Autoimmune Disease Treatment Device Market Size Growth (2021-2026)
4.5 Europe Autoimmune Disease Treatment Device Market Size Growth (2021-2026)
4.6 Middle East & Africa Autoimmune Disease Treatment Device Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Autoimmune Disease Treatment Device Market Size by Country (2021-2026)
5.2 Americas Autoimmune Disease Treatment Device Market Size by Type (2021-2026)
5.3 Americas Autoimmune Disease Treatment Device Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autoimmune Disease Treatment Device Market Size by Region (2021-2026)
6.2 APAC Autoimmune Disease Treatment Device Market Size by Type (2021-2026)
6.3 APAC Autoimmune Disease Treatment Device Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Autoimmune Disease Treatment Device Market Size by Country (2021-2026)
7.2 Europe Autoimmune Disease Treatment Device Market Size by Type (2021-2026)
7.3 Europe Autoimmune Disease Treatment Device Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Autoimmune Disease Treatment Device by Region (2021-2026)
8.2 Middle East & Africa Autoimmune Disease Treatment Device Market Size by Type (2021-2026)
8.3 Middle East & Africa Autoimmune Disease Treatment Device Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AUTOIMMUNE DISEASE TREATMENT DEVICE MARKET FORECAST
10.1 Global Autoimmune Disease Treatment Device Forecast by Region (2027-2032)
10.1.1 Global Autoimmune Disease Treatment Device Forecast by Region (2027-2032)
10.1.2 Americas Autoimmune Disease Treatment Device Forecast
10.1.3 APAC Autoimmune Disease Treatment Device Forecast
10.1.4 Europe Autoimmune Disease Treatment Device Forecast
10.1.5 Middle East & Africa Autoimmune Disease Treatment Device Forecast
10.2 Americas Autoimmune Disease Treatment Device Forecast by Country (2027-2032)
10.2.1 United States Market Autoimmune Disease Treatment Device Forecast
10.2.2 Canada Market Autoimmune Disease Treatment Device Forecast
10.2.3 Mexico Market Autoimmune Disease Treatment Device Forecast
10.2.4 Brazil Market Autoimmune Disease Treatment Device Forecast
10.3 APAC Autoimmune Disease Treatment Device Forecast by Region (2027-2032)
10.3.1 China Autoimmune Disease Treatment Device Market Forecast
10.3.2 Japan Market Autoimmune Disease Treatment Device Forecast
10.3.3 Korea Market Autoimmune Disease Treatment Device Forecast
10.3.4 Southeast Asia Market Autoimmune Disease Treatment Device Forecast
10.3.5 India Market Autoimmune Disease Treatment Device Forecast
10.3.6 Australia Market Autoimmune Disease Treatment Device Forecast
10.4 Europe Autoimmune Disease Treatment Device Forecast by Country (2027-2032)
10.4.1 Germany Market Autoimmune Disease Treatment Device Forecast
10.4.2 France Market Autoimmune Disease Treatment Device Forecast
10.4.3 UK Market Autoimmune Disease Treatment Device Forecast
10.4.4 Italy Market Autoimmune Disease Treatment Device Forecast
10.4.5 Russia Market Autoimmune Disease Treatment Device Forecast
10.5 Middle East & Africa Autoimmune Disease Treatment Device Forecast by Region (2027-2032)
10.5.1 Egypt Market Autoimmune Disease Treatment Device Forecast
10.5.2 South Africa Market Autoimmune Disease Treatment Device Forecast
10.5.3 Israel Market Autoimmune Disease Treatment Device Forecast
10.5.4 Turkey Market Autoimmune Disease Treatment Device Forecast
10.6 Global Autoimmune Disease Treatment Device Forecast by Type (2027-2032)
10.7 Global Autoimmune Disease Treatment Device Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Autoimmune Disease Treatment Device Forecast
11 KEY PLAYERS ANALYSIS
11.1 Terumo Corporation
11.1.1 Terumo Corporation Company Information
11.1.2 Terumo Corporation Autoimmune Disease Treatment Device Product Offered
11.1.3 Terumo Corporation Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Terumo Corporation Main Business Overview
11.1.5 Terumo Corporation Latest Developments
11.2 Fresenius Medical Care
11.2.1 Fresenius Medical Care Company Information
11.2.2 Fresenius Medical Care Autoimmune Disease Treatment Device Product Offered
11.2.3 Fresenius Medical Care Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Fresenius Medical Care Main Business Overview
11.2.5 Fresenius Medical Care Latest Developments
11.3 Asahi Kasei Medical
11.3.1 Asahi Kasei Medical Company Information
11.3.2 Asahi Kasei Medical Autoimmune Disease Treatment Device Product Offered
11.3.3 Asahi Kasei Medical Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Asahi Kasei Medical Main Business Overview
11.3.5 Asahi Kasei Medical Latest Developments
11.4 Baxter
11.4.1 Baxter Company Information
11.4.2 Baxter Autoimmune Disease Treatment Device Product Offered
11.4.3 Baxter Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Baxter Main Business Overview
11.4.5 Baxter Latest Developments
11.5 Therakos
11.5.1 Therakos Company Information
11.5.2 Therakos Autoimmune Disease Treatment Device Product Offered
11.5.3 Therakos Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Therakos Main Business Overview
11.5.5 Therakos Latest Developments
11.6 PhotoMedex
11.6.1 PhotoMedex Company Information
11.6.2 PhotoMedex Autoimmune Disease Treatment Device Product Offered
11.6.3 PhotoMedex Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 PhotoMedex Main Business Overview
11.6.5 PhotoMedex Latest Developments
11.7 Nikkiso Co., Ltd
11.7.1 Nikkiso Co., Ltd Company Information
11.7.2 Nikkiso Co., Ltd Autoimmune Disease Treatment Device Product Offered
11.7.3 Nikkiso Co., Ltd Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Nikkiso Co., Ltd Main Business Overview
11.7.5 Nikkiso Co., Ltd Latest Developments
11.8 SWS Hemodialysis Care Co., Ltd
11.8.1 SWS Hemodialysis Care Co., Ltd Company Information
11.8.2 SWS Hemodialysis Care Co., Ltd Autoimmune Disease Treatment Device Product Offered
11.8.3 SWS Hemodialysis Care Co., Ltd Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 SWS Hemodialysis Care Co., Ltd Main Business Overview
11.8.5 SWS Hemodialysis Care Co., Ltd Latest Developments
11.9 WEGOBP
11.9.1 WEGOBP Company Information
11.9.2 WEGOBP Autoimmune Disease Treatment Device Product Offered
11.9.3 WEGOBP Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 WEGOBP Main Business Overview
11.9.5 WEGOBP Latest Developments
11.10 Haemonetics
11.10.1 Haemonetics Company Information
11.10.2 Haemonetics Autoimmune Disease Treatment Device Product Offered
11.10.3 Haemonetics Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Haemonetics Main Business Overview
11.10.5 Haemonetics Latest Developments
11.11 Miltenyi Biotec
11.11.1 Miltenyi Biotec Company Information
11.11.2 Miltenyi Biotec Autoimmune Disease Treatment Device Product Offered
11.11.3 Miltenyi Biotec Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Miltenyi Biotec Main Business Overview
11.11.5 Miltenyi Biotec Latest Developments
11.12 B. Braun
11.12.1 B. Braun Company Information
11.12.2 B. Braun Autoimmune Disease Treatment Device Product Offered
11.12.3 B. Braun Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 B. Braun Main Business Overview
11.12.5 B. Braun Latest Developments
11.13 Kaneka
11.13.1 Kaneka Company Information
11.13.2 Kaneka Autoimmune Disease Treatment Device Product Offered
11.13.3 Kaneka Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Kaneka Main Business Overview
11.13.5 Kaneka Latest Developments
11.14 Medica S.r.l / Aferetica
11.14.1 Medica S.r.l / Aferetica Company Information
11.14.2 Medica S.r.l / Aferetica Autoimmune Disease Treatment Device Product Offered
11.14.3 Medica S.r.l / Aferetica Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Medica S.r.l / Aferetica Main Business Overview
11.14.5 Medica S.r.l / Aferetica Latest Developments
11.15 Cala Health
11.15.1 Cala Health Company Information
11.15.2 Cala Health Autoimmune Disease Treatment Device Product Offered
11.15.3 Cala Health Autoimmune Disease Treatment Device Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Cala Health Main Business Overview
11.15.5 Cala Health Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Autoimmune Disease Treatment Device Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Autoimmune Disease Treatment Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Therapeutic Apheresis Devices
Table 4. Major Players of Immunoadsorption Devices
Table 5. Major Players of Extracorporeal Photopheresis (ECP) Systems
Table 6. Major Players of Blood Purification Devices
Table 7. Major Players of Cell Therapy / Immune Modulation Devices
Table 8. Major Players of Neuromodulation Devices
Table 9. Major Players of Others
Table 10. Autoimmune Disease Treatment Device Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Autoimmune Disease Treatment Device Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Autoimmune Disease Treatment Device Market Size Market Share by Type (2021-2026)
Table 13. Major Players of Stationary Device
Table 14. Major Players of Portable Device
Table 15. Major Players of Wearable Device
Table 16. Autoimmune Disease Treatment Device Market Size CAGR by Device Mobility (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Autoimmune Disease Treatment Device Market Size by Device Mobility (2021-2026) & ($ millions)
Table 18. Global Autoimmune Disease Treatment Device Market Size Market Share by Device Mobility (2021-2026)
Table 19. Major Players of Blood Purification
Table 20. Major Players of Immune Modulation
Table 21. Major Players of Inflammation Suppression
Table 22. Major Players of Neuromodulation
Table 23. Major Players of Biologic Drug Administration
Table 24. Major Players of Others
Table 25. Autoimmune Disease Treatment Device Market Size CAGR by Therapeutic Mechanism (2021 VS 2025 VS 2032) & ($ millions)
Table 26. Global Autoimmune Disease Treatment Device Market Size by Therapeutic Mechanism (2021-2026) & ($ millions)
Table 27. Global Autoimmune Disease Treatment Device Market Size Market Share by Therapeutic Mechanism (2021-2026)
Table 28. Autoimmune Disease Treatment Device Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 29. Global Autoimmune Disease Treatment Device Market Size by Application (2021-2026) & ($ millions)
Table 30. Global Autoimmune Disease Treatment Device Market Size Market Share by Application (2021-2026)
Table 31. Global Autoimmune Disease Treatment Device Revenue by Player (2021-2026) & ($ millions)
Table 32. Global Autoimmune Disease Treatment Device Revenue Market Share by Player (2021-2026)
Table 33. Autoimmune Disease Treatment Device Key Players Head office and Products Offered
Table 34. Autoimmune Disease Treatment Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 35. New Products and Potential Entrants
Table 36. Mergers & Acquisitions, Expansion
Table 37. Global Autoimmune Disease Treatment Device Market Size by Region (2021-2026) & ($ millions)
Table 38. Global Autoimmune Disease Treatment Device Market Size Market Share by Region (2021-2026)
Table 39. Global Autoimmune Disease Treatment Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 40. Global Autoimmune Disease Treatment Device Revenue Market Share by Country/Region (2021-2026)
Table 41. Americas Autoimmune Disease Treatment Device Market Size by Country (2021-2026) & ($ millions)
Table 42. Americas Autoimmune Disease Treatment Device Market Size Market Share by Country (2021-2026)
Table 43. Americas Autoimmune Disease Treatment Device Market Size by Type (2021-2026) & ($ millions)
Table 44. Americas Autoimmune Disease Treatment Device Market Size Market Share by Type (2021-2026)
Table 45. Americas Autoimmune Disease Treatment Device Market Size by Application (2021-2026) & ($ millions)
Table 46. Americas Autoimmune Disease Treatment Device Market Size Market Share by Application (2021-2026)
Table 47. APAC Autoimmune Disease Treatment Device Market Size by Region (2021-2026) & ($ millions)
Table 48. APAC Autoimmune Disease Treatment Device Market Size Market Share by Region (2021-2026)
Table 49. APAC Autoimmune Disease Treatment Device Market Size by Type (2021-2026) & ($ millions)
Table 50. APAC Autoimmune Disease Treatment Device Market Size by Application (2021-2026) & ($ millions)
Table 51. Europe Autoimmune Disease Treatment Device Market Size by Country (2021-2026) & ($ millions)
Table 52. Europe Autoimmune Disease Treatment Device Market Size Market Share by Country (2021-2026)
Table 53. Europe Autoimmune Disease Treatment Device Market Size by Type (2021-2026) & ($ millions)
Table 54. Europe Autoimmune Disease Treatment Device Market Size by Application (2021-2026) & ($ millions)
Table 55. Middle East & Africa Autoimmune Disease Treatment Device Market Size by Region (2021-2026) & ($ millions)
Table 56. Middle East & Africa Autoimmune Disease Treatment Device Market Size by Type (2021-2026) & ($ millions)
Table 57. Middle East & Africa Autoimmune Disease Treatment Device Market Size by Application (2021-2026) & ($ millions)
Table 58. Key Market Drivers & Growth Opportunities of Autoimmune Disease Treatment Device
Table 59. Key Market Challenges & Risks of Autoimmune Disease Treatment Device
Table 60. Key Industry Trends of Autoimmune Disease Treatment Device
Table 61. Global Autoimmune Disease Treatment Device Market Size Forecast by Region (2027-2032) & ($ millions)
Table 62. Global Autoimmune Disease Treatment Device Market Size Market Share Forecast by Region (2027-2032)
Table 63. Global Autoimmune Disease Treatment Device Market Size Forecast by Type (2027-2032) & ($ millions)
Table 64. Global Autoimmune Disease Treatment Device Market Size Forecast by Application (2027-2032) & ($ millions)
Table 65. Terumo Corporation Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 66. Terumo Corporation Autoimmune Disease Treatment Device Product Offered
Table 67. Terumo Corporation Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Terumo Corporation Main Business
Table 69. Terumo Corporation Latest Developments
Table 70. Fresenius Medical Care Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 71. Fresenius Medical Care Autoimmune Disease Treatment Device Product Offered
Table 72. Fresenius Medical Care Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Fresenius Medical Care Main Business
Table 74. Fresenius Medical Care Latest Developments
Table 75. Asahi Kasei Medical Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 76. Asahi Kasei Medical Autoimmune Disease Treatment Device Product Offered
Table 77. Asahi Kasei Medical Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Asahi Kasei Medical Main Business
Table 79. Asahi Kasei Medical Latest Developments
Table 80. Baxter Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 81. Baxter Autoimmune Disease Treatment Device Product Offered
Table 82. Baxter Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Baxter Main Business
Table 84. Baxter Latest Developments
Table 85. Therakos Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 86. Therakos Autoimmune Disease Treatment Device Product Offered
Table 87. Therakos Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Therakos Main Business
Table 89. Therakos Latest Developments
Table 90. PhotoMedex Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 91. PhotoMedex Autoimmune Disease Treatment Device Product Offered
Table 92. PhotoMedex Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. PhotoMedex Main Business
Table 94. PhotoMedex Latest Developments
Table 95. Nikkiso Co., Ltd Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 96. Nikkiso Co., Ltd Autoimmune Disease Treatment Device Product Offered
Table 97. Nikkiso Co., Ltd Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Nikkiso Co., Ltd Main Business
Table 99. Nikkiso Co., Ltd Latest Developments
Table 100. SWS Hemodialysis Care Co., Ltd Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 101. SWS Hemodialysis Care Co., Ltd Autoimmune Disease Treatment Device Product Offered
Table 102. SWS Hemodialysis Care Co., Ltd Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. SWS Hemodialysis Care Co., Ltd Main Business
Table 104. SWS Hemodialysis Care Co., Ltd Latest Developments
Table 105. WEGOBP Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 106. WEGOBP Autoimmune Disease Treatment Device Product Offered
Table 107. WEGOBP Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. WEGOBP Main Business
Table 109. WEGOBP Latest Developments
Table 110. Haemonetics Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 111. Haemonetics Autoimmune Disease Treatment Device Product Offered
Table 112. Haemonetics Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Haemonetics Main Business
Table 114. Haemonetics Latest Developments
Table 115. Miltenyi Biotec Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 116. Miltenyi Biotec Autoimmune Disease Treatment Device Product Offered
Table 117. Miltenyi Biotec Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Miltenyi Biotec Main Business
Table 119. Miltenyi Biotec Latest Developments
Table 120. B. Braun Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 121. B. Braun Autoimmune Disease Treatment Device Product Offered
Table 122. B. Braun Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. B. Braun Main Business
Table 124. B. Braun Latest Developments
Table 125. Kaneka Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 126. Kaneka Autoimmune Disease Treatment Device Product Offered
Table 127. Kaneka Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Kaneka Main Business
Table 129. Kaneka Latest Developments
Table 130. Medica S.r.l / Aferetica Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 131. Medica S.r.l / Aferetica Autoimmune Disease Treatment Device Product Offered
Table 132. Medica S.r.l / Aferetica Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Medica S.r.l / Aferetica Main Business
Table 134. Medica S.r.l / Aferetica Latest Developments
Table 135. Cala Health Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 136. Cala Health Autoimmune Disease Treatment Device Product Offered
Table 137. Cala Health Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Cala Health Main Business
Table 139. Cala Health Latest Developments
Table 1. Autoimmune Disease Treatment Device Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Autoimmune Disease Treatment Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Therapeutic Apheresis Devices
Table 4. Major Players of Immunoadsorption Devices
Table 5. Major Players of Extracorporeal Photopheresis (ECP) Systems
Table 6. Major Players of Blood Purification Devices
Table 7. Major Players of Cell Therapy / Immune Modulation Devices
Table 8. Major Players of Neuromodulation Devices
Table 9. Major Players of Others
Table 10. Autoimmune Disease Treatment Device Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Autoimmune Disease Treatment Device Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Autoimmune Disease Treatment Device Market Size Market Share by Type (2021-2026)
Table 13. Major Players of Stationary Device
Table 14. Major Players of Portable Device
Table 15. Major Players of Wearable Device
Table 16. Autoimmune Disease Treatment Device Market Size CAGR by Device Mobility (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Autoimmune Disease Treatment Device Market Size by Device Mobility (2021-2026) & ($ millions)
Table 18. Global Autoimmune Disease Treatment Device Market Size Market Share by Device Mobility (2021-2026)
Table 19. Major Players of Blood Purification
Table 20. Major Players of Immune Modulation
Table 21. Major Players of Inflammation Suppression
Table 22. Major Players of Neuromodulation
Table 23. Major Players of Biologic Drug Administration
Table 24. Major Players of Others
Table 25. Autoimmune Disease Treatment Device Market Size CAGR by Therapeutic Mechanism (2021 VS 2025 VS 2032) & ($ millions)
Table 26. Global Autoimmune Disease Treatment Device Market Size by Therapeutic Mechanism (2021-2026) & ($ millions)
Table 27. Global Autoimmune Disease Treatment Device Market Size Market Share by Therapeutic Mechanism (2021-2026)
Table 28. Autoimmune Disease Treatment Device Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 29. Global Autoimmune Disease Treatment Device Market Size by Application (2021-2026) & ($ millions)
Table 30. Global Autoimmune Disease Treatment Device Market Size Market Share by Application (2021-2026)
Table 31. Global Autoimmune Disease Treatment Device Revenue by Player (2021-2026) & ($ millions)
Table 32. Global Autoimmune Disease Treatment Device Revenue Market Share by Player (2021-2026)
Table 33. Autoimmune Disease Treatment Device Key Players Head office and Products Offered
Table 34. Autoimmune Disease Treatment Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 35. New Products and Potential Entrants
Table 36. Mergers & Acquisitions, Expansion
Table 37. Global Autoimmune Disease Treatment Device Market Size by Region (2021-2026) & ($ millions)
Table 38. Global Autoimmune Disease Treatment Device Market Size Market Share by Region (2021-2026)
Table 39. Global Autoimmune Disease Treatment Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 40. Global Autoimmune Disease Treatment Device Revenue Market Share by Country/Region (2021-2026)
Table 41. Americas Autoimmune Disease Treatment Device Market Size by Country (2021-2026) & ($ millions)
Table 42. Americas Autoimmune Disease Treatment Device Market Size Market Share by Country (2021-2026)
Table 43. Americas Autoimmune Disease Treatment Device Market Size by Type (2021-2026) & ($ millions)
Table 44. Americas Autoimmune Disease Treatment Device Market Size Market Share by Type (2021-2026)
Table 45. Americas Autoimmune Disease Treatment Device Market Size by Application (2021-2026) & ($ millions)
Table 46. Americas Autoimmune Disease Treatment Device Market Size Market Share by Application (2021-2026)
Table 47. APAC Autoimmune Disease Treatment Device Market Size by Region (2021-2026) & ($ millions)
Table 48. APAC Autoimmune Disease Treatment Device Market Size Market Share by Region (2021-2026)
Table 49. APAC Autoimmune Disease Treatment Device Market Size by Type (2021-2026) & ($ millions)
Table 50. APAC Autoimmune Disease Treatment Device Market Size by Application (2021-2026) & ($ millions)
Table 51. Europe Autoimmune Disease Treatment Device Market Size by Country (2021-2026) & ($ millions)
Table 52. Europe Autoimmune Disease Treatment Device Market Size Market Share by Country (2021-2026)
Table 53. Europe Autoimmune Disease Treatment Device Market Size by Type (2021-2026) & ($ millions)
Table 54. Europe Autoimmune Disease Treatment Device Market Size by Application (2021-2026) & ($ millions)
Table 55. Middle East & Africa Autoimmune Disease Treatment Device Market Size by Region (2021-2026) & ($ millions)
Table 56. Middle East & Africa Autoimmune Disease Treatment Device Market Size by Type (2021-2026) & ($ millions)
Table 57. Middle East & Africa Autoimmune Disease Treatment Device Market Size by Application (2021-2026) & ($ millions)
Table 58. Key Market Drivers & Growth Opportunities of Autoimmune Disease Treatment Device
Table 59. Key Market Challenges & Risks of Autoimmune Disease Treatment Device
Table 60. Key Industry Trends of Autoimmune Disease Treatment Device
Table 61. Global Autoimmune Disease Treatment Device Market Size Forecast by Region (2027-2032) & ($ millions)
Table 62. Global Autoimmune Disease Treatment Device Market Size Market Share Forecast by Region (2027-2032)
Table 63. Global Autoimmune Disease Treatment Device Market Size Forecast by Type (2027-2032) & ($ millions)
Table 64. Global Autoimmune Disease Treatment Device Market Size Forecast by Application (2027-2032) & ($ millions)
Table 65. Terumo Corporation Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 66. Terumo Corporation Autoimmune Disease Treatment Device Product Offered
Table 67. Terumo Corporation Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Terumo Corporation Main Business
Table 69. Terumo Corporation Latest Developments
Table 70. Fresenius Medical Care Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 71. Fresenius Medical Care Autoimmune Disease Treatment Device Product Offered
Table 72. Fresenius Medical Care Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Fresenius Medical Care Main Business
Table 74. Fresenius Medical Care Latest Developments
Table 75. Asahi Kasei Medical Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 76. Asahi Kasei Medical Autoimmune Disease Treatment Device Product Offered
Table 77. Asahi Kasei Medical Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Asahi Kasei Medical Main Business
Table 79. Asahi Kasei Medical Latest Developments
Table 80. Baxter Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 81. Baxter Autoimmune Disease Treatment Device Product Offered
Table 82. Baxter Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Baxter Main Business
Table 84. Baxter Latest Developments
Table 85. Therakos Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 86. Therakos Autoimmune Disease Treatment Device Product Offered
Table 87. Therakos Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Therakos Main Business
Table 89. Therakos Latest Developments
Table 90. PhotoMedex Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 91. PhotoMedex Autoimmune Disease Treatment Device Product Offered
Table 92. PhotoMedex Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. PhotoMedex Main Business
Table 94. PhotoMedex Latest Developments
Table 95. Nikkiso Co., Ltd Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 96. Nikkiso Co., Ltd Autoimmune Disease Treatment Device Product Offered
Table 97. Nikkiso Co., Ltd Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Nikkiso Co., Ltd Main Business
Table 99. Nikkiso Co., Ltd Latest Developments
Table 100. SWS Hemodialysis Care Co., Ltd Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 101. SWS Hemodialysis Care Co., Ltd Autoimmune Disease Treatment Device Product Offered
Table 102. SWS Hemodialysis Care Co., Ltd Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. SWS Hemodialysis Care Co., Ltd Main Business
Table 104. SWS Hemodialysis Care Co., Ltd Latest Developments
Table 105. WEGOBP Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 106. WEGOBP Autoimmune Disease Treatment Device Product Offered
Table 107. WEGOBP Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. WEGOBP Main Business
Table 109. WEGOBP Latest Developments
Table 110. Haemonetics Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 111. Haemonetics Autoimmune Disease Treatment Device Product Offered
Table 112. Haemonetics Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Haemonetics Main Business
Table 114. Haemonetics Latest Developments
Table 115. Miltenyi Biotec Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 116. Miltenyi Biotec Autoimmune Disease Treatment Device Product Offered
Table 117. Miltenyi Biotec Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Miltenyi Biotec Main Business
Table 119. Miltenyi Biotec Latest Developments
Table 120. B. Braun Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 121. B. Braun Autoimmune Disease Treatment Device Product Offered
Table 122. B. Braun Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. B. Braun Main Business
Table 124. B. Braun Latest Developments
Table 125. Kaneka Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 126. Kaneka Autoimmune Disease Treatment Device Product Offered
Table 127. Kaneka Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Kaneka Main Business
Table 129. Kaneka Latest Developments
Table 130. Medica S.r.l / Aferetica Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 131. Medica S.r.l / Aferetica Autoimmune Disease Treatment Device Product Offered
Table 132. Medica S.r.l / Aferetica Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Medica S.r.l / Aferetica Main Business
Table 134. Medica S.r.l / Aferetica Latest Developments
Table 135. Cala Health Details, Company Type, Autoimmune Disease Treatment Device Area Served and Its Competitors
Table 136. Cala Health Autoimmune Disease Treatment Device Product Offered
Table 137. Cala Health Autoimmune Disease Treatment Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Cala Health Main Business
Table 139. Cala Health Latest Developments
LIST OF FIGURES
Figure 1. Autoimmune Disease Treatment Device Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Autoimmune Disease Treatment Device Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Autoimmune Disease Treatment Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Autoimmune Disease Treatment Device Sales Market Share by Country/Region (2025)
Figure 8. Autoimmune Disease Treatment Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Autoimmune Disease Treatment Device Market Size Market Share by Type in 2025
Figure 10. Global Autoimmune Disease Treatment Device Market Size Market Share by Device Mobility in 2025
Figure 11. Global Autoimmune Disease Treatment Device Market Size Market Share by Therapeutic Mechanism in 2025
Figure 12. Autoimmune Disease Treatment Device in Systemic Autoimmune Diseases
Figure 13. Global Autoimmune Disease Treatment Device Market: Systemic Autoimmune Diseases (2021-2026) & ($ millions)
Figure 14. Autoimmune Disease Treatment Device in Gastrointestinal Autoimmune Disease
Figure 15. Global Autoimmune Disease Treatment Device Market: Gastrointestinal Autoimmune Disease (2021-2026) & ($ millions)
Figure 16. Autoimmune Disease Treatment Device in Neurological Autoimmune Disorders
Figure 17. Global Autoimmune Disease Treatment Device Market: Neurological Autoimmune Disorders (2021-2026) & ($ millions)
Figure 18. Autoimmune Disease Treatment Device in Autoimmune Kidney Disease
Figure 19. Global Autoimmune Disease Treatment Device Market: Autoimmune Kidney Disease (2021-2026) & ($ millions)
Figure 20. Autoimmune Disease Treatment Device in Dermatological Autoimmune Conditions
Figure 21. Global Autoimmune Disease Treatment Device Market: Dermatological Autoimmune Conditions (2021-2026) & ($ millions)
Figure 22. Global Autoimmune Disease Treatment Device Market Size Market Share by Application in 2025
Figure 23. Global Autoimmune Disease Treatment Device Revenue Market Share by Player in 2025
Figure 24. Global Autoimmune Disease Treatment Device Market Size Market Share by Region (2021-2026)
Figure 25. Americas Autoimmune Disease Treatment Device Market Size 2021-2026 ($ millions)
Figure 26. APAC Autoimmune Disease Treatment Device Market Size 2021-2026 ($ millions)
Figure 27. Europe Autoimmune Disease Treatment Device Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Autoimmune Disease Treatment Device Market Size 2021-2026 ($ millions)
Figure 29. Americas Autoimmune Disease Treatment Device Value Market Share by Country in 2025
Figure 30. United States Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Autoimmune Disease Treatment Device Market Size Market Share by Region in 2025
Figure 35. APAC Autoimmune Disease Treatment Device Market Size Market Share by Type (2021-2026)
Figure 36. APAC Autoimmune Disease Treatment Device Market Size Market Share by Application (2021-2026)
Figure 37. China Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 41. India Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Autoimmune Disease Treatment Device Market Size Market Share by Country in 2025
Figure 44. Europe Autoimmune Disease Treatment Device Market Size Market Share by Type (2021-2026)
Figure 45. Europe Autoimmune Disease Treatment Device Market Size Market Share by Application (2021-2026)
Figure 46. Germany Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 47. France Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Autoimmune Disease Treatment Device Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Autoimmune Disease Treatment Device Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Autoimmune Disease Treatment Device Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 60. APAC Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 61. Europe Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 63. United States Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 64. Canada Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 65. Mexico Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 66. Brazil Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 67. China Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 68. Japan Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 69. Korea Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 71. India Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 72. Australia Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 73. Germany Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 74. France Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 75. UK Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 76. Italy Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 77. Russia Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 78. Egypt Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 79. South Africa Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 80. Israel Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 81. Turkey Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 82. Global Autoimmune Disease Treatment Device Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Autoimmune Disease Treatment Device Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 1. Autoimmune Disease Treatment Device Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Autoimmune Disease Treatment Device Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Autoimmune Disease Treatment Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Autoimmune Disease Treatment Device Sales Market Share by Country/Region (2025)
Figure 8. Autoimmune Disease Treatment Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Autoimmune Disease Treatment Device Market Size Market Share by Type in 2025
Figure 10. Global Autoimmune Disease Treatment Device Market Size Market Share by Device Mobility in 2025
Figure 11. Global Autoimmune Disease Treatment Device Market Size Market Share by Therapeutic Mechanism in 2025
Figure 12. Autoimmune Disease Treatment Device in Systemic Autoimmune Diseases
Figure 13. Global Autoimmune Disease Treatment Device Market: Systemic Autoimmune Diseases (2021-2026) & ($ millions)
Figure 14. Autoimmune Disease Treatment Device in Gastrointestinal Autoimmune Disease
Figure 15. Global Autoimmune Disease Treatment Device Market: Gastrointestinal Autoimmune Disease (2021-2026) & ($ millions)
Figure 16. Autoimmune Disease Treatment Device in Neurological Autoimmune Disorders
Figure 17. Global Autoimmune Disease Treatment Device Market: Neurological Autoimmune Disorders (2021-2026) & ($ millions)
Figure 18. Autoimmune Disease Treatment Device in Autoimmune Kidney Disease
Figure 19. Global Autoimmune Disease Treatment Device Market: Autoimmune Kidney Disease (2021-2026) & ($ millions)
Figure 20. Autoimmune Disease Treatment Device in Dermatological Autoimmune Conditions
Figure 21. Global Autoimmune Disease Treatment Device Market: Dermatological Autoimmune Conditions (2021-2026) & ($ millions)
Figure 22. Global Autoimmune Disease Treatment Device Market Size Market Share by Application in 2025
Figure 23. Global Autoimmune Disease Treatment Device Revenue Market Share by Player in 2025
Figure 24. Global Autoimmune Disease Treatment Device Market Size Market Share by Region (2021-2026)
Figure 25. Americas Autoimmune Disease Treatment Device Market Size 2021-2026 ($ millions)
Figure 26. APAC Autoimmune Disease Treatment Device Market Size 2021-2026 ($ millions)
Figure 27. Europe Autoimmune Disease Treatment Device Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Autoimmune Disease Treatment Device Market Size 2021-2026 ($ millions)
Figure 29. Americas Autoimmune Disease Treatment Device Value Market Share by Country in 2025
Figure 30. United States Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Autoimmune Disease Treatment Device Market Size Market Share by Region in 2025
Figure 35. APAC Autoimmune Disease Treatment Device Market Size Market Share by Type (2021-2026)
Figure 36. APAC Autoimmune Disease Treatment Device Market Size Market Share by Application (2021-2026)
Figure 37. China Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 41. India Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Autoimmune Disease Treatment Device Market Size Market Share by Country in 2025
Figure 44. Europe Autoimmune Disease Treatment Device Market Size Market Share by Type (2021-2026)
Figure 45. Europe Autoimmune Disease Treatment Device Market Size Market Share by Application (2021-2026)
Figure 46. Germany Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 47. France Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Autoimmune Disease Treatment Device Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Autoimmune Disease Treatment Device Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Autoimmune Disease Treatment Device Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Autoimmune Disease Treatment Device Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 60. APAC Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 61. Europe Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 63. United States Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 64. Canada Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 65. Mexico Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 66. Brazil Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 67. China Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 68. Japan Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 69. Korea Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 71. India Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 72. Australia Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 73. Germany Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 74. France Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 75. UK Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 76. Italy Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 77. Russia Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 78. Egypt Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 79. South Africa Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 80. Israel Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 81. Turkey Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
Figure 82. Global Autoimmune Disease Treatment Device Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Autoimmune Disease Treatment Device Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Autoimmune Disease Treatment Device Market Size 2027-2032 ($ millions)
